8.79
price down icon6.98%   -0.66
after-market Handel nachbörslich: 8.96 0.17 +1.93%
loading

Rocket Pharmaceuticals Inc Aktie (RCKT) Neueste Nachrichten

pulisher
08:31 AM

Rocket Pharmaceuticals Inc (NASDAQ: RCKT)’s Stock Adds 0.53%, Making It A Good Investment - Stocks Register

08:31 AM
pulisher
03:24 AM

What is William Blair’s Estimate for RCKT Q1 Earnings? - Defense World

03:24 AM
pulisher
02:29 AM

What is Leerink Partnrs’ Estimate for RCKT Q2 Earnings? - Defense World

02:29 AM
pulisher
01:50 AM

Chardan Capital Cuts Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $54.00 - Defense World

01:50 AM
pulisher
01:50 AM

Needham & Company LLC Cuts Rocket Pharmaceuticals (NASDAQ:RCKT) Price Target to $42.00 - Defense World

01:50 AM
pulisher
Mar 02, 2025

Rocket Pharmaceuticals price target lowered to $15 from $29 at Goldman Sachs - MSN

Mar 02, 2025
pulisher
Mar 02, 2025

When Will Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Turn A Profit? - Yahoo Finance Australia

Mar 02, 2025
pulisher
Mar 01, 2025

Decoding Rocket Pharmaceuticals Inc (RCKT): A Strategic SWOT Ins - GuruFocus.com

Mar 01, 2025
pulisher
Mar 01, 2025

Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus - MSN

Mar 01, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals Advances Gene Therapy Pipeline - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Posts Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Sets New 12-Month LowHere's What Happened - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Promising Outlook for Rocket Pharmaceuticals: Buy Rating Reiterated with $32 Price Target - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals Rings the Opening Bell - Nasdaq

Feb 28, 2025
pulisher
Feb 28, 2025

Cantor Fitzgerald cuts Rocket Pharmaceuticals target to $50 By Investing.com - Investing.com Canada

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals price target lowered to $54 from $62 at Chardan - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 28, 2025
pulisher
Feb 28, 2025

Rocket Pharmaceuticals: Q4 Earnings Snapshot - The Washington Post

Feb 28, 2025
pulisher
Feb 27, 2025

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress - BioSpace

Feb 27, 2025
pulisher
Feb 27, 2025

Rocket Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Rocket Pharmaceuticals: Q4 Earnings Snapshot -February 27, 2025 at 04:15 pm EST - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

ROCKET PHARMACEUTICALS, INC. SEC 10-K Report - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Gene Therapy Pioneer Rocket Pharmaceuticals Secures Funding Through 2026 Despite Wider Losses - StockTitan

Feb 27, 2025
pulisher
Feb 26, 2025

Rocket Pharmaceuticals Inc (RCKT) may enjoy gains as insiders got busy in the recent days - Knox Daily

Feb 26, 2025
pulisher
Feb 26, 2025

Selling Rocket Pharmaceuticals Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - Simply Wall St

Feb 26, 2025
pulisher
Feb 25, 2025

Rocket Pharmaceuticals Executives Cash Out: See Who Sold Big! - TipRanks

Feb 25, 2025
pulisher
Feb 22, 2025

Rocket Pharmaceuticals (RCKT) Projected to Post Quarterly Earnings on Monday - Defense World

Feb 22, 2025
pulisher
Feb 19, 2025

Long Term Trading Analysis for (RCKT) - Stock Traders Daily

Feb 19, 2025
pulisher
Feb 17, 2025

2 Soaring Stocks to Hold for the Next 20 Years - The Globe and Mail

Feb 17, 2025
pulisher
Feb 17, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Feb 17, 2025
pulisher
Feb 14, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Hits New 52-Week LowHere's Why - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Sovran Advisors LLC Acquires New Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

RCKT stock touches 52-week low at $9.76 amid market challenges - MSN

Feb 14, 2025
pulisher
Feb 13, 2025

Strategic Financial Concepts LLC Takes Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World

Feb 13, 2025
pulisher
Feb 12, 2025

Rocket Pharma Is A Buy At These Prices With Promising Data (NASDAQ:RCKT) - Seeking Alpha

Feb 12, 2025
pulisher
Feb 10, 2025

Jennison Associates LLC Purchases 29,564 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat

Feb 10, 2025
pulisher
Feb 10, 2025

It makes sense and dollars to buy Rocket Pharmaceuticals Inc (RCKT) stock - SETE News

Feb 10, 2025
pulisher
Feb 08, 2025

(RCKT) Long Term Investment Analysis - Stock Traders Daily

Feb 08, 2025
pulisher
Feb 07, 2025

Rocket Pharmaceuticals Inc (RCKT) Shares Plummet Below 1-Year High - The News Heater

Feb 07, 2025
pulisher
Feb 05, 2025

What was Rocket Pharmaceuticals Inc (RCKT)’s performance in the last session? - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

Holdings of Rocket Pharmaceuticals Inc (RCKT) are aligned with the stars - SETE News

Feb 04, 2025
pulisher
Feb 04, 2025

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Purchased by SG Americas Securities LLC - MarketBeat

Feb 04, 2025
$310.03
price down icon 3.13%
$19.13
price down icon 7.54%
$22.96
price up icon 1.23%
$33.86
price up icon 0.65%
biotechnology ONC
$245.53
price down icon 9.67%
$111.56
price down icon 1.20%
Kapitalisierung:     |  Volumen (24h):